Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001749272-21-000001
Filing Date
2021-07-01
Accepted
2021-07-01 13:06:53
Documents
1
Effectiveness Date
2021-07-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13374
  Complete submission text file 0001749272-21-000001.txt   14439
Mailing Address 35 CAMBRIDGEPARK DR. SUITE 100 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DR. SUITE 100 CAMBRIDGE MA 02140 617-863-3636
Glympse Bio, Inc. (Filer) CIK: 0001749272 (see all company filings)

EIN.: 474956987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-368862 | Film No.: 211065064